Nephrology

List all Categories



Biomarkers in Traumatic Brain Injury

A strategy using the combined measurement of the biomarkers glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase-L1 (UCH-L1) has 100% sensitivity and 100% negative predictive value for ruling out intracranial injury in patients with mild traumatic brain injury.

  • True
  • False
Volume 41.1 - Question 18

Renal Failure Among Canadian Immigrants

Immigrants to Canada are more likely to develop incident adverse kidney outcomes compared to non-immigrants.

  • True
  • False
Volume 40.6 - Question 32

Anticoagulation in Dialysis Patients with Atrial Fibrillation

Which one of the following statements regarding the use of Factor Xa inhibitors, as compared to vitamin K antagonists, in atrial fibrillation patients on dialysis is false?

  • There is a reduced risk of major bleeding.
  • There is no difference in risk of stroke and systemic embolism.
  • There is no difference in risk of acute coronary syndrome.
  • There is increased mortality.
Volume 40.5 - Question 25

Migraine Headache Prophylaxis

Candesartan is effective for prevention of episodic and chronic migraines.

  • True
  • False
Volume 40.5 - Question 21

SGLT2s in SLE and Type 2 Diabetes

The use of Sodium Glucose cotransporter-2 inhibitors in patients with Systemic Lupus Erythematosus and Type 2 Diabetes is associated with reduction in the risk of Lupus nephritis.

  • True
  • False
Volume 40.1 - Question 25

Pediatric UTI

A 5-day treatment of acute febrile UTIs in children with oral amoxicillin-clavulanic acid was non-inferior to a 10-day treatment.

  • True
  • False
Volume 39.6 - Question 14

Chronic Kidney Disease and Preventing Hospitalization

In patients with chronic kidney disease, type 2 diabetes, and hypertension (the kidney-dysfunction triad) the use of an EHR-based algorithm and practice facilitators embedded in primary care to assist providers in delivering guideline-based interventions reduces hospitalization rate at 1 year. 

  • True
  • False
Volume 39.5 - Question 3

Empagliflozin and Chronic Kidney Disease

In patients with chronic kidney disease empagliflozin reduces the risk of kidney disease progression.

  • True
  • False
Volume 39.3 - Question 39

Back to Previous Page